Restenosis: The mouse that roared

Circulation

Volumn 108, Issue 3, 2003, Pages 248-249

  King III, Spencer B ^a,b  

^a Cardiology of Georgia   (United States)

^b Fuqua Heart Center   (United States)

Author keywords

Editorials; Restenosis; Stents

Indexed keywords

RAPAMYCIN;

ATHEROSCLEROSIS; CORONARY STENT; DISEASE COURSE; EDITORIAL; FOLLOW UP; HUMAN; INTIMA; INTRAVASCULAR ULTRASOUND; PRIORITY JOURNAL; RESTENOSIS;

ANIMALS; CORONARY RESTENOSIS; DRUG ADMINISTRATION ROUTES; DRUG IMPLANTS; HUMANS; MICE; REOPERATION; RISK ASSESSMENT; SIROLIMUS; STENTS; TREATMENT OUTCOME;

EID: 0041807670     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000082927.86409.8D     Document Type: Editorial

References (5)

1. Morice MC, Serruys PW, Sousa JE, et al, for the RAVEL study group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780.
2. Moses JW, Leon MB, Popma JJ, et al. Drug-eluting stent trials: a multicenter randomized clinical study of the sirolimus-eluting stent in native coronary lesions: clinical outcomes. Circulation. 2002;106:II-392. Abstract.
3. Lemos PA, Saia F, Ligthart JMR, et al. Coronary restenosis after sirolimus-eluting stent implantation: morphological description and mechanistic analysis from a consecutive series of cases. Circulation. 2003;108:257-260.
4. Weintraub WS, Ghazzal ZMB, Douglas JS Jr, et al. Long-term clinical follow-up in patients with angiographic restudy after successful angioplasty. Circulation. 1993;87:831-840.
5. Serruys PW. Status of sirolimus. Presented at the Scientific Sessions of the American College of Cardiology, Chicago. Ill, March 30, 2003.